S100A2 and cancer: Diminished S100A2 expression has also been described in a cell line model study of early lung cancer (Feng et al, 2001) and a number of other cancers, including head and neck cancer (Nagy et al, 2001) and skin melanoma (Maelandsmo et al, 1997).